Also listed on Pharmaceutical Advisors LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Sep 1, 2042 · High confidence
20-year base term ends Sep 1, 2042
Held by Empathbio, Inc.
Filed Sep 1, 2022 as application 17/901,504 · Granted May 28, 2024
Base term, 20 years from filing
Today
2022
2042
Clock starts
Sep 1, 2022
Sep 1, 2022
Term ends
Sep 1, 2042
Sep 1, 2042
Granted
May 28, 2024
May 28, 2024
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 12,492,178, to Sep 1, 2042. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 1, 2022, when this application, 17/901,504, was filed | Sep 1, 2042 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,492,178) | resolves to Sep 1, 2042, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 1, 2042 | High confidence |
This family
| US 11,993,577 | this patent Sep 2042 | Sep 2042 |
| US 12,492,178 | In force Dec 2043 | Dec 2043 |
| Application 19/366,168 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2022 Reel 62084, frame 241 | Fawaz, Majed | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Feb 10, 2023 Reel 62662, frame 798 | Morra, Nicholas | Pharmaceutical Advisors, LLC | Assignment of Assignor's Interest |
| Feb 13, 2023 Reel 62677, frame 953 | Pharmaceutical Advisors, LLC | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Sep 20, 2023 Reel 64970, frame 164 | Atai Life Sciences AG | Empathbio, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2042
Term ends Sep 1, 2042. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 12,492,178, ends no earlier than this term, so it caps nothing.
Citations
5
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.